EC approves Cabotegravir LA by ViiV Healthcare for HIV prevention

ViiV Healthcare, majorly owned by GSK with Pfizer and Shionogi as shareholders, announced that the European Commission (EC) has authorized Apretude, also known as cabotegravir ... Read More